| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUGCGCUGUGCUCGAGGGGUGCCGGCCAGGCCUGAGCGAGCGAGCUAG… | 1943 nt | 0.6330 | |
| CCACAGGCCAAGUGCGCUGUGCUCGAGGGGUGCCGGCCAGGCCUGAGCG… | 1773 nt | 0.6294 | |
| CCACAGGCCAAGUGCGCUGUGCUCGAGGGGUGCCGGCCAGGCCUGAGCG… | 1768 nt | 0.6307 | |
| CCACAGGCCAAGUGCGCUGUGCUCGAGGGGUGCCGGCCAGGCCUGAGCG… | 1935 nt | 0.6388 | |
| CCACAGGCCAAGUGCGCUGUGCUCGAGGGGUGCCGGCCAGGCCUGAGCG… | 1236 nt | 0.5518 |
This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
A study in humans demonstrated that the CDKN1C exhibited decreased mRNA and protein levels in placental samples of smaller twins from growth-discordant dizygotic pairs [Dany Laure Wadji et al. DOI:10.1371/journal.pone.0315549]. In a separate human study, abdominal subcutaneous adipose tissue transcriptome analysis showed that the CDKN1C was down-regulated in response to short-term overfeeding [Shea et al. DOI:10.3945/ajcn.2008.25970].